Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Accumulated OCI history
Currency unavailable · from the balance sheet
No Accumulated OCI data reported for this period type.
Accumulated OCI vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $3.06M USD | -22.1% | -4.4% | 1.6% | |
| Mar 2026 | $22K USD | -94.9% | — | 0.0% | |
| Mar 2026 | -$146K USD | -190.7% | — | 0.0% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | -$683K USD | -3204.5% | — | 0.1% |
| Jun 2026 | -$828K USD | -5420.0% | — | 0.1% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | -€966K EUR | — | — | 0.6% |
ORKAOruka Therapeutics, Inc. | Sep 2026 | -$5.04M USD | -2824.9% | — | 0.4% |
| Sep 2026 | -$5.38M USD | -780.4% | — | 0.5% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -780.4% | -4.4% | 0.3% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.